Complex relationships between endocrinopathies and obstructive sleep apnea syndrome
DOI:
https://doi.org/10.15584/ejcem.2017.3.11Keywords:
obstructive sleep apnea, endocrinopathies, diabetesAbstract
Sleep-related disordered breathing (SRDB) is a term covering a heterogeneous group of conditions with a similar clinical picture yet different pathogenesis. Nocturnal episodes of obstructive apnoea, leading to repeated periods of desaturation and re-oxygenation, activate chemoreceptors and increase the activity of the sympathetic as well as renin-angiotensin-aldosterone system. Moreover, the generation of free radicals and proinflammatory cytokines increases. All the above mentioned disturbances interfere with the function of endocrine glands. On the other hand, many endocrine disorders are associated with an increased risk of obstructive sleep apnoea syndrome (OSAS). In this paper, we discuss relationships between selected endocrinopathies and OSAS.
Downloads
References
Marin J, Carrizo S. Mortality in obstructive sleep apnea. Sleep Med Clin. 2007;2(4):593-601.
Kiciński P, Zakrzewski M, Dybała A, Zubilewicz R, Mosiewicz J, Jaroszyński A. Obturacyjny bezdech senny – zasady diagnostyki i leczenia. Forum Med Rodzinnej. 2012;6(5): 228-235.
Ruchała M, Bromińska B, Cyrańska-Chyrek E, Kuźnar-Kamińska B, Kostrzewska M, Batura-Gabryel H. Obstructive sleep apnea and hormones - a novel insight. Arch Med Sci. 2017;13(4):875-884.
Young T, Peppard P, Gottlieb D. Epidemiology of obstructive sleep apnea. A population health perspective. Am J Respir Crit Care Med. 2002;165:1217-1239.
Sorensen J, Winther K, Bonnema S, Godballe C, Hegedüs L. Respiratory manifestations of hypothyroidism: a systematic review. Thyroid. 2016;26(11):1519-1527.
Mete T, Yalcin Y, Berker D, et al. Relationship between obstructive sleep apnea syndrome and thyroid diseases. Endocrine. 2013;44:723.
Resta O, Pannacciulli N, Di Gioia G, Stefàno A, Foschino Barbaro M, De Pergola G. High prevalence of previously unknown subclinical hypothyroidism in obese patients referred to a sleep clinic for sleep disordered breathing. Nutr Metab Cardiovasc Dis. 2004;14(5):248-253.
Petrone A, Mormile F, Bruni G, Quartieri M, Bonsignore MR, Marrone O. Abnormal thyroid hormones and non-thyroidal illness syndrome in obstructive sleep apnea, and effects of CPAP treatment. Sleep Med. 2016;23:21-25.
Jha A, Sharma S, Tandon N, et al. Thyroxine replacement therapy reverses sleep-disordered breathing in patients with primary hypothyroidism. Sleep Med. 2006;7(1):55-61.
Frick K, Bushinsky D. Chronic metabolic acidosis reversibly inhibits extracellular matrix gene expression in mouse osteoblasts. Am J Physiol. 1998;275:840-847.
Bushinsky D, Chabala J. Effects of in vivo metabolic acidosis on midcortical bone ion composition. Am J Physiol. 1999;277:813-819.
Terzi R, Yılmaz Z. Bone mineral density and changes in bone metabolism in patients with obstructive sleep apnea syndrome. J Bone Miner Metab. 2016;34(4):475-481.
ChenY-L, Weng S-F, Shen Y-C, et al. Obstructive sleep spnea and risk of osteoporosis: a population-based cohort study in Taiwan. J Clin Endocrinol Metab. 2014; 99(7):2441-2447.
Grace C, Vincent R, Aylwin S. High prevalence of vitamin D insufficiency in a United Kingdom urban morbidly obese population: implications for testing and treatment. Surg Obes Relat Dis. 2014;10(2):355-360.
Barceló A, Esquinas C, Piérola J, et al. Vitamin D status and parathyroid hormone levels in patients with obstructive sleep apnea. Respiration. 2013;86(4):295-301.
Liguori C, Romigi A, Izzi F, et al. Continuous positive airway pressure treatment increases serum vitamin D levels in pale Patients with obstructive sleep apnea. J Clin Sleep Med. 2015; 11(6):603-607.
McCarty D, Chesson A, Jain S, Marino A. The link between vitamin D metabolism and sleep medicine. Sleep Med Rev. 2014;18:311–319.
Kritikou I, Basta M, Vgontzas A, et al. Sleep apnoea and the hypothalamic-pituitary-adrenal axis in men and women: effects of continuous positive airway pressure. Eur Respir J. 2016;47(2):531-540.
Carneiro G, Togeiro S, Hayashi L, et al. Effect of continuous positive airway pressure therapy on hypothalamic-pituitary-adrenal axis function and 24-h blood pressure profile in obese men with obstructive sleep apnea syndrome. Am J Physiol Endocrinol Metab. 2008;295(2):380-384.
Wang L, Wang TY Bai Y, Hsu J, et al. Risk of obstructive sleep apnea among patients with Cushing's syndrome: a nationwide longitudinal study. Sleep Med. 2017;36:44-47.
Turan O, Akinci B, Ikiz AO, et al. Airway and sleep disorders in patients with acromegaly. Clin Respir J. 2017; doi: 10.1111/crj.12618 (access on-line 08 Nov 2017).
Pivonello R, Auriemma RS, Grasso LF, et al. Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities. Pituitary. 2017;20,1: 46-62.
Powlson A, Gurnell M. Cardiovascular Disease and Sleep-Disordered Breathing in Acromegaly. Neuroendocrinol. 2016;103(1):75-85.
Weiss V, Sonka K, Pretl M, et al. Prevalence of the sleep apnea syndrome in acromegaly population. J Endocrinol Invest. 2000;23(8):515-519.
Sesmilo G, Resmini E, Sambo M, et al. Prevalence of acromegaly in patients with symptoms of sleep apnea. PLoS One. 2017;12,9: e0183539.
Miranda-Rius J, Brunet-LLobet L, Lahor-Soler E, de Dios-Miranda D, Giménez-Rubio J. GH-secreting pituitary macroadenoma (acromegaly) associated with progressive dental malocclusion and refractory CPAP treatment. Head Face Med. 2017;13,1:7.
Grunstein R, Ho K Sullivan CE. Effect of octreotide, a somatostatin analog, on sleep apnea in patients with acromegaly. Ann Intern Med. 1994;121:478-483.
Foster G, Sanders M, Millman R, et al. Obstructive sleep apnea among obese patients with type 2 diabetes. Diabetes Care. 2009,32(6):1017-1019.
Lindberg E, Theorell-Haglow J, Svensson M, Gislason T, Berne C, Janson C. Sleep apnea and glucose metabolism — a long-term follow-up in a community-based sample. Chest. 2012; 42(4):935-942.
Katz S, MacLean J, Hoey L, et al. Insulin Resistance and Hypertension in Obese Youth With Sleep-Disordered Breathing Treated With Positive Airway Pressure: A Prospective Multicenter Study. J Clin Sleep Med. 2017;15,13(9):1039-1047.
Peng C, Cao Y, Tian Y, Zhang W, Xia J, Yang L. Features of continuous glycemic profile and glycemic variability in patients with obstructive sleep apnea syndrome. Diabetes Res Clin Pract. 2017;134:106-112.
West S, Groves D, Lipinski H, et al. The prevalence of retinopathy in men with type 2 diabetes and obstructive sleep apnoea. Diabet Med. 2010;27:423–430.
Mentek M, Aptel F, Godin-Ribuot D, Tamisier R, Pepin J, Chiquet C. Diseases of the retina and the optic nerve associated with obstructive sleep apnea. Sleep Med Rev. 2017: 1087-0792(17)30107-7.
Yayan J, Rasche K, Vlachou A. Obstructive Sleep Apnea and Chronic Kidney Disease. Adv Exp Med Biol. 2017;1022:11-18.
Misra A, Shrivastava U. Obstructive Sleep Apnea and Diabetic Nephropathy. Diabetes Technol Ther. 2016;18(7):405-407.
Chang A, Fox T, Wang S, Wu A. Relationship between obstructive sleep apnea and the presence and the severity of diabetic retinopathy. Retina. 2017; doi: 10.1097/IAE.0000000000001848 (access on-line: 08 Nov 2017).
Altaf Q, Dodson P, Ali A, et al. Obstructive Sleep Apnea and Retinopathy in Patients with Type 2 Diabetes. A Longitudinal Study. Am J Respir Crit Care Med. 2001;196,7:892-900.
Tahrani A, Ali A, Raymond N, et al. Obstructive sleep apnea and diabetic neuropathy: a novel association in patients with type 2 diabetes. Am J Respir Crit Care Med. 2012;186(5): 434-441.
Babu A, Herdegen J, Fogelfeld L, Shott S, Mazzone T. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med. 2005; 165(4):447-452.
Harsch I, Schahin S, Radespiel-Tröger M, et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 2004;169(2):156-162.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 European Journal of Clinical and Experimental Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
